These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. International update: new findings on promising medications. Litten RZ Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):216A-218A. PubMed ID: 8947268 [No Abstract] [Full Text] [Related]
3. Current pharmacotherapies of alcoholism: a U.S. perspective. Anton RF; Swift RM Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780 [TBL] [Abstract][Full Text] [Related]
4. The pharmacological treatment of alcohol dependence. Swift RM Med Health R I; 1997 Mar; 80(3):91-3. PubMed ID: 9117944 [No Abstract] [Full Text] [Related]
5. [Acamprosate and naltrexone: similar efficacy for relapse]. Saitz R Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019 [No Abstract] [Full Text] [Related]
6. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Bouza C; Angeles M; Muñoz A; Amate JM Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577 [TBL] [Abstract][Full Text] [Related]
7. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Johnson BA; Ait-Daoud N Psychopharmacology (Berl); 2000 May; 149(4):327-44. PubMed ID: 10867960 [TBL] [Abstract][Full Text] [Related]
8. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review. Soyka M; Rösner S Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726 [TBL] [Abstract][Full Text] [Related]
10. New pharmacotherapies for alcohol dependence. Graham R; Wodak AD; Whelan G Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353 [TBL] [Abstract][Full Text] [Related]
11. Preserved DNA from past clinical trials yields new information about a subtype of alcoholism. O'Brien CP Curr Psychiatry Rep; 2008 Oct; 10(5):375-6. PubMed ID: 18803909 [No Abstract] [Full Text] [Related]
12. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Boening JA; Lesch OM; Spanagel R; Wolffgramm J; Narita M; Sinclair D; Mason BJ; Wiesbeck GA Alcohol Clin Exp Res; 2001 May; 25(5 Suppl ISBRA):127S-131S. PubMed ID: 11391061 [TBL] [Abstract][Full Text] [Related]
13. Does the alcoholic's remedy come in a pill? Gordon SM Behav Healthc Tomorrow; 2001 Aug; 10(4):SR29-30, SR34. PubMed ID: 11496583 [No Abstract] [Full Text] [Related]
14. Occurrence and management of depression in the context of naltrexone treatment of alcoholism. Farren CK; O'Malley SS Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269 [No Abstract] [Full Text] [Related]
15. Recent advances in the pharmacotherapy of alcoholism. Myrick H; Anton R Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological review of alcoholic dependence treatment]. Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J Vertex; 2008; 19(77):512-21. PubMed ID: 18443665 [TBL] [Abstract][Full Text] [Related]
18. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. Mason BJ Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Snyder JL; Bowers TG Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575 [TBL] [Abstract][Full Text] [Related]
20. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. Johnson BA; Ait-Daoud N; Roache JD J Stud Alcohol Suppl; 2005 Jul; (15):157-67; discussion 140. PubMed ID: 16223067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]